Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2026 04:58 ET | Source: Arletta Pharma Solutions

Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US

FDA endorses key elements of Arletta Pharma's Phase 2 study of Lybrido, a dual-action therapy for women with FSIAD/HSDD, and opens path to a single Phase 3
July 15, 2026 09:00 ET | Source: Persephoni Bio

Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury

Persephoni backs SelSym Biotech to bring the first shelf-stable, blood-type agnostic hemostatic therapy to the point of injury, expanding trauma access.
July 14, 2026 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management

AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
July 14, 2026 08:35 ET | Source: MediPharm Labs Corp.

MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia

Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with...
July 09, 2026 13:00 ET | Source: BCC Research LLC

Modular Microfactories Market to Reach $12.8 Billion by 2030, Driven by Government Initiatives and Supply Chain Resilience Needs

Analyzes emerging technologies, patent activity & competitive developments shaping next generation of decentralized, highly automated manufacturing systems
July 09, 2026 08:05 ET | Source: Scienture Holdings, Inc.

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers

Commercial availability expected in August as the Company advances the rollout of the highest-dose FDA-approved naloxone hydrochloride nasal spray U.S. naloxone market totals ~$144 million in annual...
July 07, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Microfluidic Devices Market Size/Share Worth USD 182.98 Billion by 2035 at a 22.36% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 08, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Microfluidic Devices Market Size, Trends and Insights By Device Type (Chips,...
July 07, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global Infant Medicine Syringes Market Size/Share Worth USD 1108.13 Million by 2035 at a 5.89% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Infant Medicine Syringes Market Size, Trends and Insights By Type (Oral Syringes,...
July 06, 2026 00:30 ET | Source: Custom Market Insights

[Latest] Global Beadlets Capsule Market Size/Share Worth USD 968.45 Million by 2035 at a 6.85% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Beadlets Capsule Market Size, Trends and Insights By Type (Vitamin Beadlets,...
July 01, 2026 08:51 ET | Source: SERB Pharmaceuticals

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

SERB Pharmaceuticals has completed the acquisition of development and commercialization rights to Idefirix (imlifidase) in Europe